Intrinsiqq
Global X Genomics & Biotechnology ETF logo

Global X Genomics & Biotechnology ETF

GNOMETF · Nasdaq

$72.47

+$0.96 (+1.35%)

EOD Oct 29, 2026

Compare GNOM with another ETF

Key facts

Expense ratio
0.5%
Dividend yield (TTM)
0.08%
Distributions
Annual
Fund net assets (Aug 2026)
$92M
Stocks held
50
Other positions
6
Turnover (last fiscal year)
16.51%
52-week range
$41.16 to $74.19

Top 10 holdings

All holdings

48.8% of assets in ten stocks, as of Aug 31, 2026

GNOM top 10 holdings by weight
CompanyWeightQuality
Moderna, Inc.MRNA7.50%20
Twist Bioscience CorporationTWST6.34%40
10x Genomics Inc.TXG5.48%48
Guardant Health Inc.GH5.28%30
Illumina, Inc.ILMN4.87%68
NATERA INC (Common Stock) – ticker 45ENTRA4.60%61
GEGenscript Biotech Corp3.81%n/a
Vertex Pharmaceuticals IncorporatedVRTX3.70%47
Bio-Techne CorporationTECH3.67%52
Biomarin Pharmaceutical Inc.BMRN3.58%51

Sector allocation

Share of the fund's assets

  • Healthcare83.6%
  • Industrials12.6%

Scores of what it owns

Every holding's score

Each holding's score, weighted by its size in the fund

42Qualityout of 1009Dividendout of 100

0% of the fund's stock weight sits in companies with a Quality score above 75, 65% in companies below 50.

Where it invests

Stock weight by the company's home country

  • United States95.0%
  • Hong Kong SAR China3.8%
  • United Kingdom1.2%

Growth of $10,000

With and without the dividends reinvested

GNOM pays annual. Over the last twelve months it paid $0.06 per share, a 0.08% yield at today's price. The latest payment was $0.06, ex-dividend Jun 29, 2026. Over five years the annual payout grew -23.9% a year.

GNOM questions

What does GNOM invest in?+

Global X Genomics & Biotechnology ETF is an exchange-traded fund. Its largest holdings are Moderna, Inc. (7.50%), Twist Bioscience Corporation (6.34%), 10x Genomics Inc. (5.48%).

What is GNOM's expense ratio?+

0.5% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $50.00 a year.

How much does GNOM pay in dividends?+

GNOM paid $0.06 per share over the last twelve months, a 0.08% yield at the Oct 29, 2026 close of $72.47. It pays annual.

How good are the companies GNOM owns?+

Weighted by position size, the stocks in GNOM average a Quality score of 42 out of 100. 0% of the fund's stock weight sits in companies scoring above 75, 65% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.

More on GNOM: Holdings · Dividend history

Holdings: the fund's latest SEC Form N-PORT, as of Aug 31, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to n/a. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 29, 2026.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.